These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3403257)

  • 21. The intrinsic activities of the partial dopamine receptor agonists (-)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats.
    Carlsson M; Carlsson A; Eriksson E
    Eur J Pharmacol; 1987 Oct; 142(1):39-43. PubMed ID: 3691635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
    Horowski R
    Adv Neurol; 1982; 33():325-34. PubMed ID: 7055013
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of adrenalectomy and dexamethasone treatment on prolactin secretion of lactating rats.
    Horváth KM; Bánky Z; Tóth BE; Halász B; Nagy GM
    Brain Res Bull; 2001 Dec; 56(6):589-92. PubMed ID: 11786246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Prolactin and migraine.
    Horrobin DF
    Lancet; 1974 Sep; 2(7882):717-8. PubMed ID: 4142985
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum prolactin and migraine.
    Masoud SA; Fakharian E
    Ann Saudi Med; 2005; 25(6):489-91. PubMed ID: 16438460
    [No Abstract]   [Full Text] [Related]  

  • 26. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
    Van Loon GR; De Souza EB; Shin SH
    Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum prolactin as an index of dopamine receptor blockade in acute schizophrenia [proceedings].
    Cotes PM; Crow TJ; Johnstone EC
    Br J Clin Pharmacol; 1977 Oct; 4(5):651P. PubMed ID: 911637
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
    González LC; Pinilla L; Tena-Sempere M; Aguilar E
    J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The age-related characteristics of the dopaminergic regulation of prolactin secretion in men].
    Gubernatorov EE; Gerasimov GA; Bershinskiĭ VP; Pivovarov SA; Orlov KV
    Probl Endokrinol (Mosk); 1993; 39(2):22-4. PubMed ID: 8016045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defective dopaminergic regulation of prolactin secretion in a rat pituitary tumour cell line.
    Malarkey WB; Groshong JC; Milo GE
    Nature; 1977 Apr; 266(5603):640-1. PubMed ID: 859630
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention of migraine by reducing prolactin levels.
    Horrobin DF
    Lancet; 1973 Apr; 1(7806):777. PubMed ID: 4120760
    [No Abstract]   [Full Text] [Related]  

  • 32. The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats.
    Svensson K; Carlsson M; Carlsson A; Hjorth S; Johansson AM; Eriksson E
    Eur J Pharmacol; 1986 Nov; 130(3):237-42. PubMed ID: 3792447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselective inhibition of prolactin secretion by (-)-HW-165, a novel 3-PPP congener; further support for similarities between central DA autoreceptors and pituitary lactotroph DA receptors.
    Hjorth S; Eriksson E; Andersson B
    Eur J Pharmacol; 1986 Jun; 125(3):421-8. PubMed ID: 3755402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential TSH and PRL responses to dopamine receptor blockade in acromegaly.
    Prescott RW; Weightman DR; Kendall-Taylor P; Johnston DG
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):369-75. PubMed ID: 6509782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary evidence that a dopamine receptor antagonist blocks the prolactin-inhibitory effects of melatonin in anosmic male rats.
    Blask DE; Nodelman JL; Leadem CA
    Experientia; 1980 Aug; 36(8):1008-9. PubMed ID: 7439322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine.
    Rainero I; Valfrè W; Savi L; Gentile S; Pinessi L; Gianotti L; Arvat E; Ghigo E; Del Rizzo P; Calvelli P; Limone P
    J Endocrinol Invest; 2001 May; 24(5):310-4. PubMed ID: 11407649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopaminergic stimulation of prolactin release.
    Denef C; Manet D; Dewals R
    Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of two dopamine agonists, TL-99 and 3-PPP, on prolactin secretion in the rat.
    Gudelsky GA; Passaro E; Meltzer HY
    Eur J Pharmacol; 1983 Jun; 90(4):423-5. PubMed ID: 6884430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.
    De Camilli P; Macconi D; Spada A
    Nature; 1979 Mar; 278(5701):252-4. PubMed ID: 423973
    [No Abstract]   [Full Text] [Related]  

  • 40. Human foetal prolactin but not thyrotropin secretion is decreased by bromocriptine.
    Roti E; Robuschi G; Alboni A; d'Amato L; Montermini M; Gardini E; Salvi M; Borciani E; Dall'Aglio E; Bisi S
    Acta Endocrinol (Copenh); 1986 May; 112(1):35-42. PubMed ID: 3716756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.